Trials / Completed
CompletedNCT03103620
Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
Safety And Effectiveness Evaluation Of COBRA PzF™ Coronary Stent System: A French Observational Postmarketing Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,027 (actual)
- Sponsor
- CeloNova BioSciences, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, prospective, consecutive enrolled, observational registry. The population being studied includes all patients undergoing treatment of "de novo" lesions in native coronary vessels, saphenous vein graft and/or arterial bypass conduits with the COBRA PzF coronary stent system. The registry will primarily assess the rate of MACE (cardiac death, myocardial infarction and clinically driven target lesion revascularization.
Conditions
- Stable Angina
- Unstable Angina
- ACS - Acute Coronary Syndrome
- STEMI
- NSTEMI - Non-ST Segment Elevation MI
- Myocardial Infarction
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | COBRA PzF Coronary Stent System | COBRA PzF Coronary Stent System |
Timeline
- Start date
- 2015-09-10
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2017-04-06
- Last updated
- 2018-08-07
Locations
18 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03103620. Inclusion in this directory is not an endorsement.